Vous n'êtes pas identifié (connexion)

Centre de recherche

VENDREDI 15 DÉC

Calendrier >

CARRIÈRES

Liste des opportunités >

BOTTIN

André-Guy Martin

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
11 Côte du Palais, Bureau 3342
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-691-5264
Télécopieur(s)
Courriel(s)
andre-guy.martin@mail.chudequebec.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Tiberi D, Rodrigues G, Pickles T, Morris J, Crook J, Martin AG, Cury F, Catton C, Lukka H, Warner A, Taussky D. Supplementary data: External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer Canadian Urological Association journal = Journal de l’Association des urologues du Canada.,  2017. 11: E126-E127
Vigneault E, Savard J, Savard MH, Ivers H, Despres P, Foster W, Martin AG, Fradet V. Validation of the French-Canadian version of the Expanded Prostate Cancer Index Composite (EPIC) in a French-Canadian population. Canadian Urological Association journal = Journal de l’Association des urologues du Canada.,  2017. Epub
Vigneault E, Mbodji K, Magnan S, Despres P, Lavallee MC, Aubin S, Beaulieu L, Foster W, Martin AG. High-dose-rate brachytherapy boost for prostate cancer treatment: Different combinations of hypofractionated regimens and clinical outcomes. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2017. 124: 49-55
Martell K, Husain S, Taussky D, Angyalfi S, Delouya G, Despres P, Beaulieu L, Martin AG, Vigneault E. Multicenter Evaluation of Biochemical Relapse-Free Survival Outcomes for Intraoperatively Planned Prostate Brachytherapy Using an Automated Delivery System. International journal of radiation oncology, biology, physics ,  2017. Epub
Miksys N, Haidari M, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models. Medical physics,  2017. 44: 4329-4340
Loblaw A, Pickles T, Crook J, Martin AG, Vigneault E, Souhami L, Cury F, Morris J, Catton C, Lukka H, Cheung P, Sethukavalan P, Warner A, Yang Y, Rodrigues G, Genitourinary Radiation Oncologists of Canada (GUROC). Stereotactic Ablative Radiotherapy Versus Low Dose Rate Brachytherapy or External Beam Radiotherapy: Propensity Score Matched Analyses of Canadian Data. Clinical oncology (Royal College of Radiologists (Great Britain)),  2017. 29: 161-170
Tiberi D, Rodrigues G, Pickles T, Morris J, Crook J, Martin AG, Cury F, Catton C, Lukka H, Warner A, Taussky D. External validation of the ProCaRS nomograms and comparison of existing risk-stratification tools for localized prostate cancer. Canadian Urological Association journal = Journal de l’Association des urologues du Canada.,  2017. 11: 94-100
Miksys N, Vigneault E, Martin AG, Beaulieu L, Thomson RM. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy. International journal of radiation oncology, biology, physics ,  2017. 97: 606-615
Gaudet M, Vigneault E, Foster W, Meyer F, Martin AG. Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,  2016. 118: 141-7
Vigneault E, Mbodji K, Racine LG, Chevrette E, Lavallee MC, Martin AG, Despres P, Beaulieu L. Image-Guided High-Dose-Rate (HDR) Boost Localization Using MRI/MR Spectroscopy: A Correlation Study with Biopsy. Cureus,  2016. Epub
© 2017 Tous droits réservés Centre de recherche du CHU de Québec